Physician profile
Darius Gharib
NPI 1013929918
$2,302.61
in general payments reported to CMS, 2019-2025
20 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $267 · 2021: $192 · 2022: $452 · 2023: $459 · 2024: $343 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954 · Education: $17.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.97 |
| Education | $17.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $385.25 | 2021-2023 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $320.94 | 2019-2022 | |
| Genzyme Corporation | $275.00 | 2019 | |
| Exact Sciences Corporation | $267.79 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $227.92 | 2021-2025 | |
| Shockwave Medical, INC | $142.90 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Evoke Pharma, INC. | $124.87 | 2023 | Gimoti |
| Amgen INC. | $104.83 | 2020-2024 | Evenity |
| Astrazeneca Pharmaceuticals LP | $96.08 | 2019-2021 | |
| Abbott Laboratories | $89.66 | 2024-2025 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $57.59 | 2020 | |
| Pfizer INC. | $41.44 | 2020-2021 | |
| Lilly USA, LLC | $36.25 | 2019-2023 | Emgality, Jardiance |
| Allergan, INC. | $32.29 | 2020 | |
| Boston Scientific Corporation | $25.80 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $19.27 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $16.11 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.22 | 2025 | |
| Nestle Healthcare Nutrition INC. | $11.86 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darius Gharib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.